Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann M Schätzl

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Cellular and Molecular Life Sciences : CMLS|April 28, 2009
Aptamers against prion proteins and prionsSabine Gilch, Hermann M Schätzl
The FEBS Journal|February 10, 2007
Molecular basis of cerebral neurodegeneration in prion diseasesJörg Tatzelt, Hermann M Schätzl
Trends in Molecular Medicine|September 18, 2003
Promising developments bringing prion diseases closer to therapy and prophylaxisSabine Gilch, Hermann M Schätzl
Bio-Protocol|November 25, 2017
Small-scale Triton X-114 Extraction of Hydrophobic ProteinsYuzuru Taguchi, Hermann M Schätzl
Prion|January 10, 2014
Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibitionYuzuru Taguchi, Hermann M Schätzl
Bio-Protocol|November 25, 2017
Small-scale Subcellular Fractionation with Sucrose Step GradientYuzuru Taguchi, Hermann M Schätzl
Free Radical Biology & Medicine|October 1, 2008
The octarepeat region of prion protein, but not the TM1 domain, is important for the antioxidant effect of prion proteinMuriel Malaisé, Hermann M Schätzl, Alexander Bürkle
Expert Opinion on Biological Therapy|June 14, 2008
Targeting prion proteins in neurodegenerative diseaseSabine Gilch, Carmen Krammer, Hermann M Schätzl
The Journal of Biological Chemistry|November 15, 2002
Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion proteinMax Nunziante, Sabine Gilch, Hermann M Schätzl
Journal of Molecular Biology|June 19, 2007
Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formationSabine Gilch, Claudia Kehler, Hermann M Schätzl
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Cellular and Molecular Life Sciences : CMLS|April 28, 2009
Aptamers against prion proteins and prionsSabine Gilch, Hermann M Schätzl
The FEBS Journal|February 10, 2007
Molecular basis of cerebral neurodegeneration in prion diseasesJörg Tatzelt, Hermann M Schätzl
Trends in Molecular Medicine|September 18, 2003
Promising developments bringing prion diseases closer to therapy and prophylaxisSabine Gilch, Hermann M Schätzl
Bio-Protocol|November 25, 2017
Small-scale Triton X-114 Extraction of Hydrophobic ProteinsYuzuru Taguchi, Hermann M Schätzl
Prion|January 10, 2014
Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibitionYuzuru Taguchi, Hermann M Schätzl
Bio-Protocol|November 25, 2017
Small-scale Subcellular Fractionation with Sucrose Step GradientYuzuru Taguchi, Hermann M Schätzl
Free Radical Biology & Medicine|October 1, 2008
The octarepeat region of prion protein, but not the TM1 domain, is important for the antioxidant effect of prion proteinMuriel Malaisé, Hermann M Schätzl, Alexander Bürkle
Expert Opinion on Biological Therapy|June 14, 2008
Targeting prion proteins in neurodegenerative diseaseSabine Gilch, Carmen Krammer, Hermann M Schätzl
The Journal of Biological Chemistry|November 15, 2002
Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion proteinMax Nunziante, Sabine Gilch, Hermann M Schätzl
Journal of Molecular Biology|June 19, 2007
Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formationSabine Gilch, Claudia Kehler, Hermann M Schätzl
Pageof 7